NCYT:LON
Novacyt SA
GBX 39.50
arrow_downward
-0.25%(-0.100) 1D
Okt 16, 4:35:25 PM GMT+1 · GBX
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NCYT...
Buksan
GBX 39.60
Mataas
GBX 39.68
Mababa
GBX 39.20
Mkt. cap
32.41M
Avg. na dami
102.63K
Dami
12.22K
Mataas nang 52-wk
GBX 86.00
Mababa nang 52-wk
GBX 26.60
Mga natitirang share
37.66M
Bilang ng mga empleyado
228
Buksan
GBX 39.60
Mataas
GBX 39.68
Mababa
GBX 39.20
Mkt. cap
32.41M
Avg. na dami
102.63K
Dami
12.22K
Mataas nang 52-wk
GBX 86.00
Mababa nang 52-wk
GBX 26.60
Mga natitirang share
37.66M
Bilang ng mga empleyado
228
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
5 oras ang nakalipas
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
The Motley Fool
·
8 oras ang nakalipas
We Just Witnessed a Unique Stock Market Measure Do Something for Only the 4th Time Since 1997, and It Offers a Chilling Outlook for Wall Street
Bloomberg.com
·
6 araw ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
Reuters
·
4 araw ang nakalipas
Nasdaq ends down as chipmakers fall and bank earnings roll in
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Tungkol sa Novacyt SA